Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The Netherlands.

Conclusion: In The Netherlands, between 2010 and 2016, 4.5% of patients with stage IIIA NSCLC were selected for treatment with neoadjuvant therapy followed by resection. The 5-year OS in these patients exceeded 50%. However, the outcome might be overestimated due to clinical over staging. PMID: 32347142 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32347142?dopt=Abstract

Source: Acta Oncologica - April 28, 2020 Category: Cancer & Oncology Authors: Joosten PJM, Damhuis RAM, van Diessen JNA, de Langen JA, Belderbos JSA, Smit EF, Klomp HM, Veenhof AAFA, Hartemink KJ Tags: Acta Oncol Source Type: research